|
|
40
|
|
|
64212
|
|
|
NEORAL 100MG/ML SOLN (NVS/COL) CYCLOSPORIN
|
|
|
CYCLOSPORIN
|
|
|
NEORAL
|
|
|
50ML
|
|
|
BQ
|
|
|
475.71
|
|
|
475.71
|
|
|
100MG/ML
|
|
|
SOLUTION
|
|
|
0
|
|
|
BOTT
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|